2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell LymphomaHigh-risk Large B-cell Lymphoma (LBCL)Active, not recruitingPhase 32026-04-15NCT05605899
DALY II Japan/MB-CART2019.1 for DLBCLHemic and Lymphatic Diseases, Neoplasms by Histologic Type, histiocytosis, interdigitating dendritic cell sarcoma, lymphatic system disorder, malignant histiocytosis, neoplasmRecruitingPhase 22026-01-08NCT07288879